MS HB1390 | 2025 | Regular Session
Status
Completed Legislative Action
Sponsorship: Partisan Bill (Independent 1)
Status: Failed on February 4 2025 - 100% progression
Action: 2025-02-04 - Died In Committee
Text: Latest bill text (Introduced) [HTML]
Sponsorship: Partisan Bill (Independent 1)
Status: Failed on February 4 2025 - 100% progression
Action: 2025-02-04 - Died In Committee
Text: Latest bill text (Introduced) [HTML]
Summary
An Act To Create A Task Force To Conduct A Study Of The Impact Of Alternative Funding Programs On Patient Access To Affordable Prescription Drugs; To Provide That The Members Of The Task Force Shall Be Comprised Of The Members Of The Mississippi Rare Disease Advisory Council Or Their Designees; To Provide That The First Meeting Of The Task Force Shall Be Held By May 15, 2025; To Specify The Subjects And Issues That The Study Shall Consider; To Provide That The Task Force Shall Complete The Study Not Later Than December 1, 2025, And Transmit Copies Of The Study To Certain Persons, And Provide A Written Report Of Its Findings From The Study, Together With Any Recommendations For Legislation, To Certain Officials And Legislative Committees; And For Related Purposes.
Title
Affordable prescription drugs; create task force to study impact of alternative funding programs on patient access to.
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2025-02-04 | House | Died In Committee |
| 2025-01-20 | House | Referred To Public Health and Human Services |
Mississippi State Sources
| Type | Source |
|---|---|
| Summary | https://billstatus.ls.state.ms.us/2025/pdf/history/HB/HB1390.xml |
| Text | https://billstatus.ls.state.ms.us/documents/2025/html/HB/1300-1399/HB1390IN.htm |
